Literature DB >> 3118020

Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies.

D Anderson1, D Bell, R Lodge, E Grant.   

Abstract

A 37-year-old woman presented with a history of acute loss of vision in her left eye and a history of recurrent transient ischemic attacks. Subsequent investigations revealed a prolonged PTT. The lupus anticoagulant and anticardiolipin antibodies (aCL) were identified in her serum. A cardiac murmur was heard and echocardiography demonstrated a mass on the mitral valve. Extensive studies for infection were negative. Cardioembolic phenomena were considered a possible cause of her cerebral ischemic events. The occurrence of nonbacterial endocardial verrucae is well described in systemic lupus erythematosus. The pathogenesis of this lesion remains speculative, however, its occurrence in our patient, with a lupus anticoagulant and aCL suggests a possible association. The clinical manifestations of thrombosis in patients with antiphospholipid antibodies are varied, and may include the development of thrombotic endocardial lesions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118020

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome.

Authors:  G Sakaguchi; K Minami; S Nakayama; H Tsuneyoshi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-03

2.  Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

Authors:  O Meyer; M Golstein; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Coagulation abnormalities and cerebral infarction.

Authors:  M Greaves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

Review 4.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

5.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

Review 6.  Diagnosis and pathogenesis of CNS lupus.

Authors:  A P van Dam
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

7.  Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.

Authors:  R A Asherson; D G Gibson; D W Evans; E Baguley; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

8.  Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus: clinical and immunological features.

Authors:  A M Chancellor; R E Cull; D C Kilpatrick; C P Warlow
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.